Health Trials

Docetaxel

2

Review clinical trials related to Docetaxel. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors

To collect information about treatment outcomes in pediatric and adolescent patients with relapsed/refractory germ cells tumors who receive GemDMC with an ASCT.

Participants needed: 30
Trial details
Age: 21+Biological sex: AllType: ObservationalSponsor: M.D. Anderson Cancer CenterUpdated: Jun 23, 2026Locations: 1
Eligibility criteria

Male or female participants, greater than 1 month of age up to 21 years old. Neo... [+2]

Participants who do not or did not receive GemDMC as part of the conditioning re...

Read more
Status: Recruiting

Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

This is a multicenter, open-label, phase 3, randomized, non-inferiority study aimed to investigate the effect on disease-free survival of adjuvant chemotherapy with oxaliplatin plus S-1 compared with adjuvant chemotherapy with docetaxel plus S-1 after D2 gastrectomy in patients with stage III gastric cancer.

Participants needed: 387
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Ruijin HospitalUpdated: Jan 26, 2026Locations: 5
Eligibility criteria

age 18 to 80 years old, male and female [+8]

other primary malignancies, except for cured skin tumors or cervical carcinoma i... [+6]

Read more